Quidel | QDEL - Selling And Administration Expenses


Quidel reported $194.4M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Agilent USD 428M 37M Sep/2025
Avanos Medical USD 77.6M 5.9M Sep/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 283M 27M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 129M 1.3M Sep/2025
Neogen USD 107.5M 1.56M Sep/2025
OraSure Technologies USD -0.06 0.05 Sep/2024
Pacific Biosciences Of California USD 43.75M 2.13M Sep/2024
Quidel USD 194.4M 7.5M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
STAAR Surgical USD 59.38M 18.08M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Waters USD 240.01M 25.78M Dec/2025